ArticleCell reports. Medicine2023

A phase I, first-in-human study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of MRG-001 in healthy subjects.

Ali R Ahmadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.